Globus Medical Reports Third Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
Globus Medical (GMED) PT Raised to $80 at BofA Securities
November 6, 2024 5:57 AM ESTBofA Securities analyst Craig Bijou raised the price target on Globus Medical (NYSE: GMED) to $80.00 (from $55.00) while maintaining a Underperform rating.
The analyst comments "GMED continues to deliver beat and raises showing that it has managed the NuVasive integration better than... More
Globus Medical (GMED) Tops Q3 EPS by 18c
November 5, 2024 4:24 PM ESTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.83, $0.18 better than the analyst estimate of $0.65. Revenue for the quarter came in at $625.7 million versus the consensus estimate of $604.71 million.
GUIDANCE:
Globus Medical sees FY2024 EPS of $2.90-$3.00, versus the consensus of... More
